#larimar
Latest news and interesting information about larimar.
JPMorgan Initiates Larimar at Overweight
JPMorgan starts Larimar Therapeutics at Overweight with $9 target. Stock at $3.47. Key developments on nomlabofusp.
...
Latest news and interesting information about larimar.